218 related articles for article (PubMed ID: 31049998)
1. Bayesian nonparametric estimation of ROC surface under verification bias.
Zhu R; Ghosal S
Stat Med; 2019 Aug; 38(18):3361-3377. PubMed ID: 31049998
[TBL] [Abstract][Full Text] [Related]
2. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients.
Leandersson P; Åkesson A; Hedenfalk I; Malander S; Borgfeldt C
PLoS One; 2020; 15(10):e0240418. PubMed ID: 33075095
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of CA125 and HE4 in ovarian carcinoma patients and the effect of confounders on their serum levels.
Ahmed AA; Abdou AM
Curr Probl Cancer; 2019 Oct; 43(5):450-460. PubMed ID: 30670303
[TBL] [Abstract][Full Text] [Related]
4. Estimation of the volume under the receiver-operating characteristic surface adjusting for non-ignorable verification bias.
Zhang Y; Alonzo TA;
Stat Methods Med Res; 2018 Mar; 27(3):715-739. PubMed ID: 29338546
[TBL] [Abstract][Full Text] [Related]
5. The differential diagnostic value and clinical significance of serum HE4 in ovarian disease with elevated CA125.
Li W; Wang D
Arch Gynecol Obstet; 2020 May; 301(5):1219-1225. PubMed ID: 32266526
[TBL] [Abstract][Full Text] [Related]
6. Bayesian bootstrap estimation of ROC curve.
Gu J; Ghosal S; Roy A
Stat Med; 2008 Nov; 27(26):5407-20. PubMed ID: 18613217
[TBL] [Abstract][Full Text] [Related]
7. Significance of Serum Human Epididymis Protein 4 and Cancer Antigen 125 in Distinguishing Type I and Type II Epithelial Ovarian Cancers.
Yanaranop M; Jantarateptewan N; Tiyayon J; Nakrangsee S
Int J Gynecol Cancer; 2018 Jul; 28(6):1058-1065. PubMed ID: 29975290
[TBL] [Abstract][Full Text] [Related]
8. Preoperative serum levels of HE4 and CA125 predict primary optimal cytoreduction in advanced epithelial ovarian cancer: a preliminary model study.
Feng LY; Liao SB; Li L
J Ovarian Res; 2020 Feb; 13(1):17. PubMed ID: 32050995
[TBL] [Abstract][Full Text] [Related]
9. Bayesian ROC curve estimation under verification bias.
Gu J; Ghosal S; Kleiner DE
Stat Med; 2014 Dec; 33(29):5081-96. PubMed ID: 25269427
[TBL] [Abstract][Full Text] [Related]
10. Tissue CA125 and HE4 Gene Expression Levels Offer Superior Accuracy in Discriminating Benign from Malignant Pelvic Masses.
Fawzy A; Mohamed MR; Ali MA; Abd El-Magied MH; Helal AM
Asian Pac J Cancer Prev; 2016; 17(1):323-33. PubMed ID: 26838232
[TBL] [Abstract][Full Text] [Related]
11. Nearest-Neighbor Estimation for ROC Analysis under Verification Bias.
Adimari G; Chiogna M
Int J Biostat; 2015 May; 11(1):109-24. PubMed ID: 25781712
[TBL] [Abstract][Full Text] [Related]
12. A robust method using propensity score stratification for correcting verification bias for binary tests.
He H; McDermott MP
Biostatistics; 2012 Jan; 13(1):32-47. PubMed ID: 21856650
[TBL] [Abstract][Full Text] [Related]
13. Performance of preoperative plasma tumor markers HE4 and CA125 in predicting ovarian cancer mortality in women with epithelial ovarian cancer.
Furrer D; Grégoire J; Turcotte S; Plante M; Bachvarov D; Trudel D; Têtu B; Douville P; Bairati I
PLoS One; 2019; 14(6):e0218621. PubMed ID: 31220149
[TBL] [Abstract][Full Text] [Related]
14. Review of biomarker systems as an alternative for early diagnosis of ovarian carcinoma.
Srivastava A; Gupta A; Patidar S
Clin Transl Oncol; 2021 Oct; 23(10):1967-1978. PubMed ID: 33840014
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
Ren X; Zhang H; Cong H; Wang X; Ni H; Shen X; Ju S
Pathol Oncol Res; 2018 Oct; 24(4):739-744. PubMed ID: 29520570
[TBL] [Abstract][Full Text] [Related]
16. bcROCsurface: an R package for correcting verification bias in estimation of the ROC surface and its volume for continuous diagnostic tests.
To Duc K
BMC Bioinformatics; 2017 Nov; 18(1):503. PubMed ID: 29151019
[TBL] [Abstract][Full Text] [Related]
17. Ultrasound Features Improve Diagnostic Performance of Ovarian Cancer Predictors in Distinguishing Benign and Malignant Ovarian Tumors.
Chen YN; Ma F; Zhang YD; Chen L; Li CY; Gong SP
Curr Med Sci; 2020 Feb; 40(1):184-191. PubMed ID: 32166682
[TBL] [Abstract][Full Text] [Related]
18. Inverse probability weighting estimation of the volume under the ROC surface in the presence of verification bias.
Zhang Y; Alonzo TA;
Biom J; 2016 Nov; 58(6):1338-1356. PubMed ID: 27338713
[TBL] [Abstract][Full Text] [Related]
19. ROC curve estimation when covariates affect the verification process.
Rodenberg C; Zhou XH
Biometrics; 2000 Dec; 56(4):1256-62. PubMed ID: 11129488
[TBL] [Abstract][Full Text] [Related]
20. Direct estimation of the area under the receiver operating characteristic curve in the presence of verification bias.
He H; Lyness JM; McDermott MP
Stat Med; 2009 Feb; 28(3):361-76. PubMed ID: 18680124
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
